
Clinical Features and Antimicrobial Susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii Complex Isolates in Intensive Care Patients with Chronic Obstructive Pulmonary Disease and Community-Acquired Pneumonia in Taiwan
Author(s) -
Ko-Yun Chang,
Pi-Chu Wu,
Ching-Hsiao Lee,
Yu-Che Lee,
Hui-Chen Chen,
Wei-Chang Huang,
MingFeng Wu
Publication year - 2021
Publication title -
international journal of chronic obstructive pulmonary disease/international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s311714
Subject(s) - acinetobacter baumannii , medicine , pseudomonas aeruginosa , pneumonia , ventilator associated pneumonia , copd , pulmonary disease , antimicrobial , intensive care , intensive care medicine , microbiology and biotechnology , respiratory disease , community acquired pneumonia , lung , bacteria , biology , genetics
Little is known about the features and implications of Pseudomonas aeruginosa (PA) and Acinetobacter baumannii complex (ABC) isolates discovered in patients with chronic obstructive pulmonary disease (COPD) and community-acquired pneumonia (CAP) requiring invasive mechanical ventilation and admission to an intensive care unit. Thus, our study aimed to investigate the clinical characteristics and antimicrobial susceptibilities of PA and ABC isolates cultured from endotracheal aspirates (EAs) in such population.